Trial intelligence / Profile preview

Maxigesic for Postoperative Pain After VATS

NCT05366777Completed

Sponsor
Seoul National University Hospital
Start
Oct 2022
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of acetaminophen + ibuprofen in postoperative pain, sponsored by Seoul National University Hospital. Primary endpoint: Total fentanyl consumption during 24 hours. Started Oct 2022; status: completed.

02

Drugs

acetaminophen + ibuprofen
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05366777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05366777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call